Download MendeleyDesign, synthesis and structure activity relationship of potent pan-PIM kinase inhibitors derived from the pyridyl carboxamide scaffold.
Nishiguchi, G.A., Burger, M.T., Han, W., Lan, J., Atallah, G., Tamez, V., Lindvall, M., Bellamacina, C., Garcia, P., Feucht, P., Zavorotinskaya, T., Dai, Y., Wong, K.(2016) Bioorg Med Chem Lett 26: 2328-2332
- PubMed: 26995528 Search on PubMed
- DOI: https://doi.org/10.1016/j.bmcl.2016.03.037
- Primary Citation Related Structures:
5IIS - PubMed Abstract:
The Pim proteins (1, 2 and 3) are serine/threonine kinases that have been found to be upregulated in many hematological malignancies and solid tumors. As a result of overlapping functions among the three isoforms, inhibition of all three Pim kinases has become an attractive strategy for cancer therapy. Herein we describe our efforts in identifying potent pan-PIM inhibitors that are derived from our previously reported pyridyl carboxamide scaffold as part of a medicinal chemistry strategy to address metabolic stability.
- Global Discovery Chemistry, Novartis Institutes for Biomedical Research, 4560 Horton Street, Emeryville, CA 94608, United States. Electronic address: gisele.nishiguchi@novartis.com.
Organizational Affiliation:
